110 related articles for article (PubMed ID: 37546)
1. [The determination of phosphohexose isomerase in patients with cancer of breast and uterus. A comparison with other tests (author's transl)].
Telesforo P; Rosenberg R
Quad Sclavo Diagn; 1978 Sep; 15(3):365-72. PubMed ID: 37546
[TBL] [Abstract][Full Text] [Related]
2. Serum enzymes in patients with carcinoma of lung: lactic-acid dehydrogenase, phosphohexose isomerase, alkaline phosphatase and glutamic oxaloacetic transaminase.
Gault MH; Cohen MW; Kahana LM; Leelin FT; Meakins JF; Aronovitch M
Can Med Assoc J; 1967 Jan; 96(2):87-94. PubMed ID: 6017171
[TBL] [Abstract][Full Text] [Related]
3. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
Paulick R; Caffier H; Paulick M
Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of the combined use of plurime tumor markers in human breast cancer.
Neri B; Bartalucci S; Cataliotti L; Distante V; Tommasi M; Ciapini A
Cancer Detect Prev; 1988; 13(2):115-21. PubMed ID: 3072081
[TBL] [Abstract][Full Text] [Related]
5. [Value of phosphohexose isomerase (PHI) determination in myocardial infarct].
Guidollet J; Devic J; Ripoll JP
Arch Mal Coeur Vaiss; 1975 Oct; 68(10):1103-8. PubMed ID: 816276
[TBL] [Abstract][Full Text] [Related]
6. [Significance of laboratory chemical parameters for the detection of metastases in breast cancer].
Pirich K; Graninger W; Schneeweiss B; Schuster R; Lenzhofer R; Gabl F
Wien Klin Wochenschr; 1983 Nov; 95(22):778-81. PubMed ID: 6142567
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of the determination of serum phosphohexose isomerase in malignant neoplasms].
Bruno GF; Failla G; Foti E; Marchese V
Minerva Med; 1978 Mar; 69(12):749-56. PubMed ID: 643216
[TBL] [Abstract][Full Text] [Related]
8. [A comparison of serum phosphohexose isomerase and sialyl transferase activities in patients with malignant disease].
Bayer PM; Ganzinger U; Burger EC; Gergely T; Gabl F; Moser K
Wien Klin Wochenschr; 1977 Jan; 89(1):16-7. PubMed ID: 556872
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen and phosphohexose isomerase, gammaglutamyl transpeptidase and lactate dehydorgenase levels in patients with and without liver metastases.
Munjal D; Chawla PL; Lokich JJ; Zamcheck N
Cancer; 1976 Apr; 37(4):1800-7. PubMed ID: 4219
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients.
Yasasever V; Dinçer M; Camlica H; Duranyildiz D; Dalay N
Eur J Gynaecol Oncol; 1997; 18(5):397-9. PubMed ID: 9378161
[TBL] [Abstract][Full Text] [Related]
11. Glycolytic enzymes in human breast carcinoma cytosols: the influence of commonly used reference parameters.
Oglobine J; Spyratos F; Lidereau R; Brault C; Desplaces A
Cancer Detect Prev; 1985; 8(1-2):67-70. PubMed ID: 4064053
[TBL] [Abstract][Full Text] [Related]
12. Biochemical studies in breast carcinoma. 1. Serum phosphohexose isomerase, lactate dehydrogenase and its isoenzyme changes.
Saravanan CS; Balasubramanian MK; Gopalakrishnan V; Govindarajulu P; Nanjunda Rao R
Indian J Cancer; 1977 Mar; 14(1):38-41. PubMed ID: 885568
[No Abstract] [Full Text] [Related]
13. Metabolic changes in breast carcinoma. II. Phosphohexose isomerase and lactic dehydrogenase levels in serum.
Maity CR; Burma DP
Indian J Cancer; 1973 Sep; 10(3):356-60. PubMed ID: 4785884
[No Abstract] [Full Text] [Related]
14. Enzyme tests in cancer.
Schwartz MK
Clin Lab Med; 1982 Sep; 2(3):479-91. PubMed ID: 6128099
[No Abstract] [Full Text] [Related]
15. Clinical significance of serum lactate dehydrogenase, phosphohexose isomerase, aldolase and hexokinase in prostatic carcinoma.
Yeshowardhana
Indian J Physiol Pharmacol; 1985; 29(1):33-8. PubMed ID: 2414222
[TBL] [Abstract][Full Text] [Related]
16. [Combination of cancer markers in the detection and prognosis of digestive system tumors].
de Mello Júnior JP; Giles GR
Arq Gastroenterol; 1986; 23(3):133-44. PubMed ID: 2449153
[TBL] [Abstract][Full Text] [Related]
17. Serum tumor markers in metastatic breast cancer and course of disease.
Caffier H; Brandau H
Cancer Detect Prev; 1983; 6(4-5):451-7. PubMed ID: 6197167
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of phosphoisomerase and lactate dehydrogenase in pediatric oncological pathology].
Calculli G; Vaglia A; Astori L; Prandini BD; Speziali G
Quad Sclavo Diagn; 1979 Mar; 15(1):60-73. PubMed ID: 232278
[TBL] [Abstract][Full Text] [Related]
19. Plasma acid and alkaline phosphatase in patients with breast cancer.
Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of serum phosphohexose isomerase in metastatic breast cancer].
Paulick R; Caffier H
Med Klin (Munich); 1987 May; 82(11):385-91. PubMed ID: 3600541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
